The iGene Personal Health and Disease Risk Panel provides an invaluable health assessment to individuals in understanding their inherited and risks and preventative options in three actionable health areas that most critically shape the disease forecast of today.
Breast cancer affects about 1 in 8 (~12.29%) women in developed countries in their lifetime and accounts for 1/3 of the cancers in women.
Inherited cardiomyopathies may lead to serious complications including heart failure, abnormal heart rhythms, heart valve problems, or sudden cardiac arrest (SCA) at some point of their lives.
Here at ApolloGen, we are committed to translate the promise of genetic and genomic research into informative and actionable results that help individuals and their families make personalized decisions of their healthcare. ApolloGen offers unparalleled genetic expertise to patients and physicians. We understand the complexity and sensitivity of genetic information and are committed the highest level of scientific integrity and reliability. We are physicians and scientists who are experts in the field of genetic, genomics, and translational medicine.
ApolloGen is dedicated to provide pertinent genetic testing results to empower the individual to live his or her life to the fullest. As genetics become an increasingly integral part of our healthcare, we believe that genetic information should be made accessible to everyone.
Our state-of-the art sequencing laboratory is certified by the U.S. Health and Human Services’ Clinical Laboratory Improvement Amendments (CLIA) of 1988 and licensed by the state of California.
ApolloGen utilizes Next-Generation Sequencing (NGS) to optimize our testing strategies for our panels. As opposed to first generation sequencing technologies, which involve sequencing of one DNA strand at a time, NGS involves massively parallel sequencing that extends the process to millions of sequencing reactions at a time, thereby generating massive amounts of data in a short amount of time.learn more